Добірка наукової літератури з теми "CD155"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "CD155".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "CD155"
Zhang, Hongpan, Zhihao Yang, Guobo Du, Lu Cao, and BangXian Tan. "CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers." Technology in Cancer Research & Treatment 20 (January 1, 2021): 153303382098008. http://dx.doi.org/10.1177/1533033820980088.
Повний текст джерелаYoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, and Tomoharu Sugie. "Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients." PLOS ONE 16, no. 6 (June 11, 2021): e0253176. http://dx.doi.org/10.1371/journal.pone.0253176.
Повний текст джерелаZhu, Xudong, Rongpu Liang, Tianyun Lan, Dongbing Ding, Shengxin Huang, Jun Shao, Zongheng Zheng, et al. "Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer." Journal for ImmunoTherapy of Cancer 10, no. 9 (September 2022): e004219. http://dx.doi.org/10.1136/jitc-2021-004219.
Повний текст джерелаMurakami, Daisuke, Kenji Matsuda, Hiromitsu Iwamoto, Yasuyuki Mitani, Yuki Mizumoto, Yuki Nakamura, Ibu Matsuzaki, et al. "Prognostic value of CD155/TIGIT expression in patients with colorectal cancer." PLOS ONE 17, no. 3 (March 24, 2022): e0265908. http://dx.doi.org/10.1371/journal.pone.0265908.
Повний текст джерелаYan, Zhang. "Increased expression of CD155 and CD112 on monocytes in septic patients (INC6P.327)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 192.29. http://dx.doi.org/10.4049/jimmunol.194.supp.192.29.
Повний текст джерелаTang, Xiyang, Jie Yang, Anping Shi, Yanlu Xiong, Miaomiao Wen, Zhonglin Luo, Huanhuan Tian, et al. "CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways." Cancers 14, no. 22 (November 15, 2022): 5610. http://dx.doi.org/10.3390/cancers14225610.
Повний текст джерелаLi, Yu-Chen, Quan Zhou, Qing-Kun Song, Rui-Bin Wang, Shuzhen Lyu, Xiudong Guan, Yan-Jie Zhao, and Jiang-Ping Wu. "Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study." Journal of Immunology Research 2020 (January 13, 2020): 1–9. http://dx.doi.org/10.1155/2020/3948928.
Повний текст джерелаHe, Yongning, Steffen Mueller, Paul R. Chipman, Carol M. Bator, Xiaozhong Peng, Valorie D. Bowman, Suchetana Mukhopadhyay, Eckard Wimmer, Richard J. Kuhn, and Michael G. Rossmann. "Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155." Journal of Virology 77, no. 8 (April 15, 2003): 4827–35. http://dx.doi.org/10.1128/jvi.77.8.4827-4835.2003.
Повний текст джерелаChandramohan, Vidyalakshmi, Jeffrey D. Bryant, Hailan Piao, Stephen T. Keir, Eric S. Lipp, Michaela Lefaivre, Kathryn Perkinson, Darell D. Bigner, Matthias Gromeier, and Roger E. McLendon. "Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas." Archives of Pathology & Laboratory Medicine 141, no. 12 (December 1, 2017): 1697–704. http://dx.doi.org/10.5858/arpa.2016-0580-oa.
Повний текст джерелаCho, Monica, Madison Phillips, Longzhen Song, Amy Erbe-Gurel, and Christian M. Capitini. "CD155 axis modulation promotes natural killer cell-mediated graft-versus-tumor effects against osteosarcoma." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 62.06. http://dx.doi.org/10.4049/jimmunol.208.supp.62.06.
Повний текст джерелаДисертації з теми "CD155"
Martel, André Bernard. "Targeting CD155 on Myeloid Derived Suppressor Cells to Prevent Postoperative Immunosuppression in Cancer Patients." Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/41151.
Повний текст джерелаMaier, Michael Klaus. "Studien zur Funktion von murinem CD155 bei der Migration von Leukozyten und der Entstehung einer humoralen Immunantwort." kostenfrei, 2007. http://d-nb.info/988269511/34.
Повний текст джерелаBaury, Béatrice. "CD155, un membre de la superfamille des immunoglobulines : homologies avec le gène Tage4 du rat, expression des formes membranaires et solubles." Nantes, 2002. http://www.theses.fr/2002NANT21VS.
Повний текст джерелаOur project focused on two members of the immunoglobulin superfamily, the rat Tage4 gene, which is overexpressed in rat and mice colon tumors, and the human CD155 gene coding for the poliovirus (PV) receptor. We have determined the structural organisation of the Tage4 gene by designing a DNA walking method to isolate the promoter region. Our results have underlined the existence of numerous homologies between Tage4 and CD155. Moreover, the product of the Tage4 gene can mediate entry into cells of the viruses, except PV, that use CD155 as a receptor. These structural and functional homologies suggest that the Tage4 gene is probably orthologous to the gene for CD155. Besides, we have shown by RT-PCR and immunohistochemistry that CD155 is overexpressed in colorectal carcinoma. As the carcinoembryonic antigen (CEA), the CD155 overexpression is an early event in colon carcinogenesis. However, unlike the CEA, the CD155 expression is not regulated by the interferon gamma nor by the nuclear receptor PPAR gamma (Peroxisome Proliferator-Activated Receptor). We have demonstrated the existence of CD155 secreted isoforms by immunoprecipitation in serum, in cerebrospinal fluid and in culture medium of polarised epithelial cell. .
Jassam, Samah Ali. "Role of CD15 and CD15s in the cellular mechanisms of cancer cell metastasis from lung to the brain." Thesis, University of Portsmouth, 2016. https://researchportal.port.ac.uk/portal/en/theses/role-of-cd15-and-cd15s-in-the-cellular-mechanisms-of-cancer-cell-metastasis-from-lung-to-the-brain(de581581-027d-4106-9c23-9daa534d684f).html.
Повний текст джерелаZevian, Shannin Christine. "Structure-function analysis of Tetraspanin CD151." Diss., University of Iowa, 2011. https://ir.uiowa.edu/etd/3022.
Повний текст джерелаRomanets, Olga. "Study of the role of measles virus receptor CD150 in viral immunopathogenesis and characterization of novel CD150 isoform." Phd thesis, Ecole normale supérieure de lyon - ENS LYON, 2012. http://tel.archives-ouvertes.fr/tel-00923189.
Повний текст джерелаMoyano, Rodríguez Yolanda 1992. "Mitosis exit regulation by Cdc5 and PP2A-Cdc55." Doctoral thesis, Universitat Pompeu Fabra, 2019. http://hdl.handle.net/10803/668051.
Повний текст джерелаEn esta tesis hemos investigado el papel de la fosfatasa PP2ACdc55 en la regulación de la citocinesis y la contribución de la quinasa Cdc5 en la salida de mitosis en la levadura de gemación. Previamente, se había sugerido un posible papel de la PP2ACdc55 en citocinesis basándose en el fenotipo elongado en ausencia de Cdc55. Sin embargo, la función de la PP2ACdc55 durante la citocinesis y sus sustratos no han sido estudiados. En esta tesis, hemos demostrado que la PP2ACdc55 regula la desfosforilación de las proteínas de IPC que regulan la citocinesis; así como, su tiempo de localización en el cuello. Además, hemos observado como la PP2ACdc55 realiza un papel en la coordinación de la contracción del anillo de actomiosina y la formación del septo. En cuanto a Cdc5, analizamos los posibles residuos de Net1 fosforilados por Cdc5 que contribuyen a la liberación de Cdc14 en la salida de mitosis.
Maurik, Andre van. "The role of CD40-CD154 interactions in allograft transplantation." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249302.
Повний текст джерелаDewitte, Antoine. "Plaquettes sanguines et insuffisance rénale aiguë : rôle du couple CD154/CD40 dans la constitution des lésions tubulaires." Thesis, Bordeaux, 2017. http://www.theses.fr/2017BORD0906.
Повний текст джерелаAcute kidney injury (AKI) is a common complication in critically ill patients and is associated with increased morbidity and mortality. Sepsis is the most common cause of AKI. The understanding of sepsis pathophysiology and its complications has progressed significantly in recent years but has not yet been translated into significant therapeutic advances in clinical practice. The traditional paradigm that sepsis-induced AKI is linked to renal hypoperfusion has been challenged by recent evidences showing that renal blood flow is not universally impaired during sepsis,and that AKI can develop in the presence of normal or even increased renal bloodflow. Sepsis is characterized by profound alterations of the immune response and adisproportionate inflammatory response. Inflammation and microcirculatorydysfunction are now considered as fundamental pathophysiological mechanisms atthe origin of renal injuries. Beyond haemostasis, the contribution of platelets ininflammation, tissue integrity and defence against infections has considerablywidened the spectrum of their role and made them potential physiopathologicalactors in sepsis. Platelets fulfil most of these functions through the expression ofmembrane-bound or soluble mediators. Among them, CD154 holds a peculiarposition, as platelets represent a major source of CD154 and as CD154 is a centralregulator of inflammation. Here, we provide an overview of these recentpathophysiological advances and discuss the platelets and CD154 contribution tomicrocirculatory alterations in multi-organ dysfunction in sepsis. We investigated thepro-inflammatory role of CD154 under hypoxic conditions in the renal tubularepithelium as recent data highlight the importance of hypoxia in the inflammatoryreaction. We studied the control of interleukin (IL)-6 production, a key cytokineinvolved in inflammation, by CD154 in oxygen deprivation conditions using a kidneytubular epithelial (TEC) cell line model. We also studied a murine model of kidneyinjury after ischemia/reperfusion, a model that was applied in CD154 and CD40deficient mice. We found that CD154 is a potent inducer of IL-6 secretion by TEC inhypoxia and that CD154-deficient mice regenerate earlier the tubular epithelium afterischemia/reperfusion injury. These findings may provide potential avenues for septicAKI management and therapy
Higa, Ryoko. "CD105 maintains the thermogenic program of beige adipocytes by regulating Smad2 signaling." Kyoto University, 2018. http://hdl.handle.net/2433/235056.
Повний текст джерелаКниги з теми "CD155"
Churchill, Jeremy. Honda CB/CD125 T & CM125 C twins owners workshop manual. Haynes, 1990.
Знайти повний текст джерелаBooks, Bchimak. Buchhaltung: Einfaches Einnahmen- und Ausgaben Kassenbuch Für Kleinunternehmen, Einfaches Buchhaltungsbuch Für Selbstständige, Freiberufler und Als Haushaltsbuch Für Die Buchhaltung, über 3300 Einträge Auf 120 Seiten). Cd55. Independently Published, 2021.
Знайти повний текст джерелаChronic Care for Neglected Infectious Diseases: Leprosy/Hansen's Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease. Pan American Health Organization, 2021. http://dx.doi.org/10.37774/9789275122501.
Повний текст джерелаЧастини книг з теми "CD155"
Malla, R. R., Seema Kumari, V. Gayatri Devi, Anil Badana, and G. Murali Mohan. "CD151." In Encyclopedia of Signaling Molecules, 842–46. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101599.
Повний текст джерелаMalla, R. R., Seema Kumari, V. Gayatri Devi, Anil Badana, and G. Murali Mohan. "CD151." In Encyclopedia of Signaling Molecules, 1–5. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_101599-1.
Повний текст джерелаNicholson-Weller, A. "Decay Accelerating Factor (CD55)." In Membrane Defenses Against Attack by Complement and Perforins, 7–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77014-2_2.
Повний текст джерелаCalderhead, D. M., Y. Kosaka, E. M. Manning, and R. J. Noelle. "CD40-CD154 Interactions in B-Cell Signaling." In Signal Transduction and the Coordination of B Lymphocyte Development and Function II, 73–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-59641-4_4.
Повний текст джерелаTokunaga, Osamu, Rahmawati Minhajat, and Daisuke Mori. "Tumor Angiogenesis in Cancers: Expression of CD105 Marker." In Methods of Cancer Diagnosis, Therapy, and Prognosis, 41–50. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3186-0_3.
Повний текст джерелаSeon, Ben K., and Shant Kumar. "CD105 Antibody for Targeting of Tumor Vascular Endothelial Cells." In The New Angiotherapy, 499–515. Totowa, NJ: Humana Press, 2002. http://dx.doi.org/10.1007/978-1-59259-126-8_26.
Повний текст джерелаLaw, Che-Leung, and Iqbal S. Grewal. "Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges." In Advances in Experimental Medicine and Biology, 8–36. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-89520-8_2.
Повний текст джерелаIshihara, K., and T. Hirano. "BST-1/CD157 Regulates the Humoral Immune Responses in vivo." In Human CD38 and Related Molecules, 235–55. Basel: KARGER, 2000. http://dx.doi.org/10.1159/000058772.
Повний текст джерелаMalla, Rama Rao. "CD151: A Lateral Organizer and Modulator of Tumor Microenvironment in Gastrointestinal Cancers." In Novel therapeutic approaches for gastrointestinal malignancies, 83–99. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-5471-1_6.
Повний текст джерелаJuhl, H., F. Helmig, H. Kalthoff, and B. Kremer. "Limitation der Antikörpertherapie gastrointestinaler Karzinome durch die Komplementresistenzfaktoren CD55 und CD59." In Chirurgisches Forum ’96 fur experimentelle und klinische Forschung, 455–62. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80138-9_92.
Повний текст джерелаТези доповідей конференцій з теми "CD155"
Sayitoglu, Ece C., Michael Chrobok, Anna-Maria Georgoudaki, Benjamin J. Josey, Michelle Hartman, Esha Vallabhaneni, Rajeev Herekar, et al. "Abstract A55: Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a55.
Повний текст джерелаBriukhovetska, D., J. Jobst, S. Endres, and S. Kobold. "P09.03 Activation of IL-22 signaling correlates with higher CD155 expression and stratifies poor outcomes of early-stage lung and breast cancer patients." In iTOC9 – 9th Immunotherapy of Cancer Conference, September 22–24, 2022 – Munich, Germany. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-itoc9.59.
Повний текст джерелаSong, Qingkun, and Shuzhen Lv. "Abstract P1-09-05: Overexpression of CD155 in breast cancer microenvironment, associated with higher counts of tumor-infiltrating lymphocytes and increased risk of relapse and death." In Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.sabcs19-p1-09-05.
Повний текст джерелаCao, Liang, Fatima Karzai, Andrea Apolo, Ravi Madan, Yunkai Yu, James Gulley, William Figg, and William Dahut. "Abstract 2048: Pharmacodynamic biomarker studies of TRC105 anti-endoglin (CD105) antibody revealed anti-angiogenic activity associated with CD105 depletion." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2048.
Повний текст джерелаFritchie, Karen, Steven Attia, Scott Okuno, Carola Arndt, and Steven Robinson. "Abstract B237: CD105: A therapeutic target for sarcomas." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b237.
Повний текст джерелаCron, RQ, A. Genin, and M. Brunner. "OP0139 Regulation of cd154 in systemic lupus erythematosus." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.72.
Повний текст джерелаDetchokul, Sujitra, Michael W. Parker, Elizabeth D. Williams, Olivia M. Herdiman, Melissa Davis, Kelvin Kee, Damien M. Bolton, and Albert G. Frauman. "Abstract 469: CD151 and cell motility in prostate cancer." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-469.
Повний текст джерелаSalibi, Rami, Robert M. Kottmann, Everett Porter, Richard Phipps, and Patricia J. Sime. "CD40 Ligand (CD154) Is Elevated In Fibrotic Lung Diseases." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2658.
Повний текст джерелаMichaelson, J. E., F. Zhang, X. Zhang, and H. Huang. "Traction force in tetraspanin CD151 deficient human dermal microvascular endothelial cells." In 2010 36th Annual Northeast Bioengineering Conference. IEEE, 2010. http://dx.doi.org/10.1109/nebc.2010.5458143.
Повний текст джерелаJin, Hongyan, John T. Hoff, Xinyu Deng, Ronny I. Drapkin, and Xiuwei H. Yang. "Abstract 4613: A role of integrin-associated CD151 in human ovarian cancer." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4613.
Повний текст джерелаЗвіти організацій з теми "CD155"
Zhang, Dan, Jingting Liu, Mengxia zheng, Chunyan Meng, and Jianhua Liao. Prognostic and Clinicopathological significance of CD155 Expression in Cancer Patients: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0087.
Повний текст джерелаYang, Xiuwei. Critical Roles of CD151-alpha6beta1 and CD151-alpha6beta4 Integrin Complexes in Human Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2009. http://dx.doi.org/10.21236/ada517279.
Повний текст джерелаYang, Xiuwei. CD151 Synergy With ErbB Receptors During Human Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2008. http://dx.doi.org/10.21236/ada501759.
Повний текст джерелаHemler, Martin E. Targeting of CD151 in Breast Cancer and in Breast Cancer Stem Cells. Fort Belvoir, VA: Defense Technical Information Center, April 2007. http://dx.doi.org/10.21236/ada477433.
Повний текст джерелаDimitrova, Violeta S., Vanyo I. Mitev та Antonia R. Isaeva. The α and β Subunits of CK2 Are Individually and Phenotypespecifically Involved in Autocrine and BMP4‑Triggered Regulation of Proliferation of STRO‑1+, STRO‑1-, CD105+ and CD105- Cells within Human Apical Papilla. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, грудень 2020. http://dx.doi.org/10.7546/crabs.2020.12.07.
Повний текст джерелаGranata, Joseph, Hugo Sanchez, Phillip Loeschinger, and Jodi Evans. CD105 Deficiency in Mouse Aorta-Derived Progenitor Cells Promotes an Enhanced Inflammatory Response to Lipopolysaccharide. Journal of Young Investigators, October 2018. http://dx.doi.org/10.22186/jyi.35.4.61-66.
Повний текст джерела